Mark Peakman
Corresponding author: Mark Peakman
Name/email consistency: high
- Circulating Preproinsulin Signal Peptide-Specific CD8 T Cells Restricted by the Susceptibility Molecule HLA-A24 Are Expanded at Onset of Type 1 Diabetes and Kill β-Cells. Kronenberg, D., Knight, R.R., Estorninho, M., Ellis, R.J., Kester, M.G., de Ru, A., Eichmann, M., Huang, G.C., Powrie, J., Dayan, C.M., Skowera, A., van Veelen, P.A., Peakman, M. Diabetes (2012)
- Peripheral and Islet Interleukin-17 Pathway Activation Characterizes Human Autoimmune Diabetes and Promotes Cytokine-Mediated {beta}-Cell Death. Arif, S., Moore, F., Marks, K., Bouckenooghe, T., Dayan, C.M., Planas, R., Vives-Pi, M., Powrie, J., Tree, T., Marchetti, P., Huang, G.C., Gurzov, E.N., Pujol-Borrell, R., Eizirik, D.L., Peakman, M. Diabetes (2011)
- Characterization of preparations of GAD65, proinsulin, and the islet tyrosine phosphatase IA-2 for use in detection of autoreactive T-cells in type 1 diabetes: report of phase II of the Second International Immunology of Diabetes Society Workshop for Standardization of T-cell assays in type 1 diabetes. Peakman, M., Tree, T.I., Endl, J., van Endert, P., Atkinson, M.A., Roep, B.O. Diabetes (2001)
- Antigen-specific immunotherapy for autoimmune disease: fighting fire with fire?. Peakman, M., Dayan, C.M. Immunology (2001)
- Naturally processed and presented epitopes of the islet cell autoantigen IA-2 eluted from HLA-DR4. Peakman, M., Stevens, E.J., Lohmann, T., Narendran, P., Dromey, J., Alexander, A., Tomlinson, A.J., Trucco, M., Gorga, J.C., Chicz, R.M. J. Clin. Invest. (1999)
